Controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia "AICLA"


Phase N/A Results


The number of fatal and nonfatal cerebral infarctions was 31 in the placebo (P) group, 17 in the A group and 18 in the AD group. Groups A and AD, taken together, had a significantly lower rate of stroke recurrence compared to the placebo group. There was no difference between groups A and AD.